{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:13:16Z","timestamp":1781323996727,"version":"3.54.1"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The capsular polysaccharide of<jats:italic>Neisseria meningitidis<\/jats:italic>group B (MBPS) is a polymer of alpha (2\u21928)<jats:italic>N<\/jats:italic>-acetyl neuraminic acid. The polysaccharide is chemically identical to an autoantigen, polysialic acid (PSA), and is a poor immunogen, even when conjugated to protein carriers. Immunization of mice with MBPS-protein conjugate vaccines, in which<jats:italic>N<\/jats:italic>-acetyl groups have been replaced by propionyl groups (<jats:italic>N<\/jats:italic>-Pr MBPS), elicits serum bactericidal antibodies. A subpopulation of these antibodies do not cross-react with human PSA. The reasons for the increased immunogenicity of<jats:italic>N<\/jats:italic>-Pr MBPS and the antigenic targets of the bactericidal nonautoreactive antibodies are unknown. In this study, we investigated the antigenic targets of a protective murine monoclonal antibody (MAb) prepared against a<jats:italic>N<\/jats:italic>-Pr MBPS-tetanus toxoid conjugate vaccine. Binding of the MAb to<jats:italic>N<\/jats:italic>-Pr MBPS (as demonstrated by an enzyme-linked immunosorbent assay) and bactericidal activity were inhibited by de-<jats:italic>N<\/jats:italic>-acetylated MBPS and re-<jats:italic>N<\/jats:italic>-acetylated MBPS, which indicate that<jats:italic>N<\/jats:italic>-propionyl groups are not obligatory determinants for binding. The results of affinity selection from a preparation of<jats:italic>N<\/jats:italic>-Pr MBPS and matrix-assisted laser desorption ionization-time of flight mass spectroscopic analysis indicated that the minimal epitope recognized by the MAb is a MBPS disaccharide containing one de-<jats:italic>N<\/jats:italic>-acetylated residue. Thus, the bacterial capsular epitope recognized by this bactericidal, nonautoreactive, anti-group-B MAb likely contains de-<jats:italic>N<\/jats:italic>-acetyl residues.<\/jats:p>","DOI":"10.1128\/iai.73.4.2123-2128.2005","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T03:57:31Z","timestamp":1111463851000},"page":"2123-2128","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Epitopes Recognized by a Nonautoreactive Murine Anti-<i>N<\/i>-Propionyl Meningococcal Group B Polysaccharide Monoclonal Antibody"],"prefix":"10.1128","volume":"73","author":[{"given":"Gregory R.","family":"Moe","sequence":"first","affiliation":[{"name":"Children's Hospital Oakland Research Institute, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Dave","sequence":"additional","affiliation":[{"name":"Children's Hospital Oakland Research Institute, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[{"name":"Children's Hospital Oakland Research Institute, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(89)90087-9"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.5.1776-1786.1994"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)41784-5"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00136a012"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.10.005"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00348-X"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00020a019"},{"key":"e_1_3_2_9_2","first-page":"355","volume":"2","year":"1983","unstructured":"Finne, J., M. Leinonen, and P. H. Makela. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet2:355-357.","journal-title":"Lancet"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.4.1194"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.2.364"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1327"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.4049\/jimmunol.160.10.5028","volume":"160","year":"1998","unstructured":"Granoff, D. M., A. Bartoloni, S. Ricci, E. Gallo, D. Rosa, N. Ravenscroft, V. Guarnieri, R. C. Seid, A. Shan, W. R. Usinger, S. Tan, Y. E. McHugh, and G. R. Moe. 1998. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol.160:5028-5036.","journal-title":"J. Immunol."},{"key":"e_1_3_2_14_2","first-page":"55","year":"2001","unstructured":"Guo, Z., and H. Jennings. 2001. N-Propionylation, p. 55-60. In A. J. Pollard and C. J. M. Maiden (ed.), Meningococcal vaccines: methods and protocols. Humana Press, Inc., Totowa, N.J.","journal-title":"Meningococcal vaccines: methods and protocols."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(66)90275-2"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja0210087"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.1992.11.677"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.4.1207"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","volume":"127","year":"1981","unstructured":"Jennings, H. J., and C. Lugowski. 1981. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol.127:1011-1018.","journal-title":"J. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.137.5.1708","volume":"137","year":"1986","unstructured":"Jennings, H. J., R. Roy, and A. Gamian. 1986. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J. Immunol.137:1708-1713.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.134.4.2651","volume":"134","year":"1985","unstructured":"Jennings, H. J., R. Roy, and F. Michon. 1985. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis. J. Immunol.134:2651-2657.","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08416-7"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)76560-0"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)01063-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1279"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.129.5.2172","volume":"129","year":"1982","unstructured":"Mandrell, R. E., and W. D. Zollinger. 1982. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J. Immunol.129:2172-2178.","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00399a055"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1597"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.11.5664-5675.1999"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.3762-3771.2001"},{"key":"e_1_3_2_31_2","first-page":"2451","volume":"129","year":"1983","unstructured":"Moreno, C., J. Hewitt, K. Hastings, and D. Brown. 1983. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B. J. Gen. Microbiol.129:2451-2456.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00410-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.149.3.669"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.11.1929"},{"key":"e_1_3_2_35_2","first-page":"21","year":"1995","unstructured":"Poolman, J. T., P. A. Van Der Ley, and J. Tommassen. 1995. Surface structures and secreted products of meningococci, p. 21-34. In K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons, New York, N.Y.","journal-title":"Meningococcal disease."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.346"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)85895-7"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_2_39_2","unstructured":"Seid R. 2003. Neisseria meningitidis serogroup B glycoconjugates. U.S. patent 6 638 513."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.3335-3342.2001"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3002(57)90254-8"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)44476-1"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.178.4063.871"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1086\/379375"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.73.4.2123-2128.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.73.4.2123-2128.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:11:52Z","timestamp":1706069512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.73.4.2123-2128.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1128\/IAI.73.4.2123-2128.2005"],"URL":"https:\/\/doi.org\/10.1128\/iai.73.4.2123-2128.2005","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"2004-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}